These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 8805865)

  • 1. Safety and efficacy of nandrolone decanoate for treatment of wasting in patients with HIV infection.
    Gold J; High HA; Li Y; Michelmore H; Bodsworth NJ; Finlayson R; Furner VL; Allen BJ; Oliver CJ
    AIDS; 1996 Jun; 10(7):745-52. PubMed ID: 8805865
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of nandrolone decanoate therapy on weight and lean body mass in HIV-infected women with weight loss: a randomized, double-blind, placebo-controlled, multicenter trial.
    Mulligan K; Zackin R; Clark RA; Alston-Smith B; Liu T; Sattler FR; Delvers TB; Currier JS; ;
    Arch Intern Med; 2005 Mar; 165(5):578-85. PubMed ID: 15767536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of nandrolone decanoate therapy in borderline hypogonadal men with HIV-associated weight loss.
    Strawford A; Barbieri T; Neese R; Van Loan M; Christiansen M; Hoh R; Sathyan G; Skowronski R; King J; Hellerstein M
    J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Feb; 20(2):137-46. PubMed ID: 10048900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment with nandrolone decanoate and megestrol acetate in HIV-infected men.
    Cuerda C; Zugasti A; Bretón I; Camblor M; Miralles P; García P
    Nutr Clin Pract; 2005 Feb; 20(1):93-7. PubMed ID: 16207650
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Monitoring changes in fat-free mass in HIV-positive men with hypotestosteronemia and AIDS wasting syndrome treated with gonadal hormone replacement therapy.
    Van Loan MD; Strawford A; Jacob M; Hellerstein M
    AIDS; 1999 Feb; 13(2):241-8. PubMed ID: 10202830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus.
    Sattler FR; Jaque SV; Schroeder ET; Olson C; Dube MP; Martinez C; Briggs W; Horton R; Azen S
    J Clin Endocrinol Metab; 1999 Apr; 84(4):1268-76. PubMed ID: 10199766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effects of nandrolone decanoate in wasting associated with HIV.
    Saha B; Rajadhyaksha GC; Ray SK
    J Indian Med Assoc; 2009 May; 107(5):295-9. PubMed ID: 19886384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of nandrolone decanoate compared with placebo or testosterone on HIV-associated wasting.
    Gold J; Batterham MJ; Rekers H; Harms MK; Geurts TB; Helmyr PM; Silva de Mendonça J; Falleiros Carvalho LH; Panos G; Pinchera A; Aiuti F; Lee C; Horban A; Gatell J; Phanuphak P; Prasithsirikul W; Gazzard B; Bloch M; Danner SA;
    HIV Med; 2006 Apr; 7(3):146-55. PubMed ID: 16494628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effects of nandrolone and testosterone in adult male HIV patients with AIDS wasting syndrome (AWS): a randomized, double-blind, placebo-controlled trial.
    Sardar P; Jha A; Roy D; Majumdar U; Guha P; Roy S; Banerjee R; Banerjee AK; Bandyopadhyay D
    HIV Clin Trials; 2010; 11(4):220-9. PubMed ID: 20974577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, placebo-controlled trial of nandrolone decanoate in human immunodeficiency virus-infected men with mild to moderate weight loss with recombinant human growth hormone as active reference treatment.
    Storer TW; Woodhouse LJ; Sattler F; Singh AB; Schroeder ET; Beck K; Padero M; Mac P; Yarasheski KE; Geurts P; Willemsen A; Harms MK; Bhasin S
    J Clin Endocrinol Metab; 2005 Aug; 90(8):4474-82. PubMed ID: 15914526
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss.
    Batterham MJ; Garsia R
    Int J Androl; 2001 Aug; 24(4):232-40. PubMed ID: 11454075
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anabolic steroid boosts weight.
    GMHC Treat Issues; 1996 Sep; 10(9):8-9. PubMed ID: 11363845
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of resistance exercise training and nandrolone decanoate on body composition and muscle function among patients who receive hemodialysis: A randomized, controlled trial.
    Johansen KL; Painter PL; Sakkas GK; Gordon P; Doyle J; Shubert T
    J Am Soc Nephrol; 2006 Aug; 17(8):2307-14. PubMed ID: 16825332
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial.
    Johansen KL; Mulligan K; Schambelan M
    JAMA; 1999 Apr; 281(14):1275-81. PubMed ID: 10208142
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A controlled trial of nandrolone decanoate in the treatment of rheumatoid arthritis in postmenopausal women.
    Bird HA; Burkinshaw L; Pearson D; Atkinson PJ; Leatham PA; Hill J; Raven A; Wright V
    Ann Rheum Dis; 1987 Mar; 46(3):237-43. PubMed ID: 3555359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial.
    Grinspoon S; Corcoran C; Askari H; Schoenfeld D; Wolf L; Burrows B; Walsh M; Hayden D; Parlman K; Anderson E; Basgoz N; Klibanski A
    Ann Intern Med; 1998 Jul; 129(1):18-26. PubMed ID: 9652995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial.
    Strawford A; Barbieri T; Van Loan M; Parks E; Catlin D; Barton N; Neese R; Christiansen M; King J; Hellerstein MK
    JAMA; 1999 Apr; 281(14):1282-90. PubMed ID: 10208143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anabolic therapy in patients with HIV infections].
    Gruzdev BM; Ivannikov EV; Gorbacheva ES
    Ter Arkh; 1999; 71(11):35-7. PubMed ID: 10626332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Body composition and anthropometry in bodybuilders: regional changes due to nandrolone decanoate administration.
    Hartgens F; Van Marken Lichtenbelt WD; Ebbing S; Vollaard N; Rietjens G; Kuipers H
    Int J Sports Med; 2001 Apr; 22(3):235-41. PubMed ID: 11354529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant human growth hormone in patients with HIV-associated wasting. A randomized, placebo-controlled trial. Serostim Study Group.
    Schambelan M; Mulligan K; Grunfeld C; Daar ES; LaMarca A; Kotler DP; Wang J; Bozzette SA; Breitmeyer JB
    Ann Intern Med; 1996 Dec; 125(11):873-82. PubMed ID: 8967667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.